Stock

Discussion in 'OPKO Renal' started by anonymous, Jun 1, 2019 at 2:37 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    $1.79 how shameful
     

  2. anonymous

    anonymous Guest

    Don't worry the class action law suit for the stock pump and dump scheme is just getting started. Best to bar the door at OPKO, confiscate passports and not let Frost escape to Israel so he and his wife can face the angry mob armed with pitchforks, clubs and IRA statements, what a pathetic mobster.
     
  3. anonymous

    anonymous Guest

    Thanks for the 10,000 shares I received. Already losing money since it is under $2.
     
  4. anonymous

    anonymous Guest

    Troll. No one got 10,000, and they’re not shares, they’re options. And who cares what the price is now. Might as well be $100 since you can only exercise a small portion of them now. They’re not vested. Go away.
     
  5. anonymous

    anonymous Guest

    Who cares what the price of the stock is now??? ($1.79/share). Seriously? Pose that question to Dr Frost and lets see who cares. They could have given all of us 100,000 stock options and the options are currently worthless. As they say ....the paper they are printed on is worth more than the actual options. YOU go away.
     
  6. anonymous

    anonymous Guest

    How Have Estimates Been Moving Since Then?

    In the past month, investors have witnessed a downward trend in fresh estimates. The consensus estimate has shifted -133.33% due to these changes.

    VGM Scores

    At this time, OPKO Health has a poor Growth Score of F, a grade with the same score on the momentum front. Following the exact same course, the stock was allocated a grade of F on the value side, putting it in the lowest quintile for this investment strategy.

    Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.

    Outlook

    Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise OPKO Health has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.

    Very, very sad.
     
  7. anonymous

    anonymous Guest

    OPKO reports after the bell today

    Earnings Preview: OPKO Health (OPK) Q2 Earnings Expected to Decline

    Wall Street expects a year-over-year decline in earnings on lower revenues when OPKO Health (OPK) reports results for the quarter ended June 2019
     
  8. anonymous

    anonymous Guest

    Earnings were to the high side of guidance. The stock is up after hours. BRL starting to turn it around and Rayaldee is beginning to move.
     
  9. anonymous

    anonymous Guest

    up $0.5 in after hours is hardly a reason to celebrate.
     
  10. anonymous

    anonymous Guest

    correction up $0.05
     
  11. anonymous

    anonymous Guest

    Stock @ $1.88 and its a good day for stocks
     
  12. anonymous

    anonymous Guest

    now $1.78/share

    hopeless with analysts giving a year target of $2.75/share
     
  13. anonymous

    anonymous Guest

    Heading back to under $2.00/share. Hopeless.
     
  14. anonymous

    anonymous Guest

    Add Phil Frost AKA "Fish Face Frost" to the list of famous Jewish mobsters including Bugsy Siegel, Hyman Abrams, Shondor Burns, Mickey Cohen, Meyer Lansky, Hymie Martin, Frank Rosenthal, Tick Tock Tannenbaum and Big Toe Shapiro.
     
  15. anonymous

    anonymous Guest

    This stock is as toxic as the management and company culture.
     
  16. anonymous

    anonymous Guest

    It will never change. One big cluster_____!
     
  17. anonymous

    anonymous Guest


    Another $100M stock offering, for what? So the shorts can screw with us now a hundred million more times. PF please get out of the way and let someone run the company. If anything Opko should be buying back the stock not diluting the value.
     
  18. anonymous

    anonymous Guest

    OPKO is cash poor, need to raise funds to carry for 2020. Pfizer has more milestones set for OPKO before they start paying money on the HGH. We’ve already burned through the cash they initially handed over. Make no mistake about it, the money is being sucked out by BRL. It’s a dead in the water lab, little growth and even worse reimbursement.
     
  19. anonymous

    anonymous Guest

    Dum, da, dum dum!
    IMHO stock will hit $2.75 by this time next year. What say you?
     
  20. anonymous

    anonymous Guest

    ouch......stock is at $1.90/sh. Just when you think things can’t get any worse.....they do!
    oy vey!